Contributors

Marian Laderoute

Marian Laderoute

Ph.D. Medical Sciences - Immunology

Dr. Laderoute was the lead discoverer at the Public Health Agency of Canada (PHAC) of human endogenous retrovirus K102 (HERV-K102) as a replication competent, protector foamy retrovirus unique to humans whichmay protect against RNA pandemic viruses such as HIV-1 (2007, 2015).She authored the "New Immunosenescence Paradigm, 2015" and "Clues to Finding Correlates of Risk/Protection for HIV-1 vaccines, 2018" (doi:10.12688/f1000research.11818.2). She was a Brighton Collaboration, Viral Vector Vaccines SAFETY Working Group Member (2008-2015). More recently she authored ‘A Smarter Pandemic Vaccination Strategy’ (submitted) which explains and substantiates how trained (innate) immunity vaccination may be a more suitable approach to taming the pandemic than by adaptive immunity mechanisms. Adaptive immunity which by recognizing virus-specific antigens; may select for variants, increased pathogenesis and the erosion of herd immunity. In contrast, the boosting of trained (innate) immunity can lead to durable sterilizing herd immunity against the alpha and delta variants, needed for ending the pandemic.Dr. Laderoute is a global expert in trained (innate) immunity involving the production of HERV-K102 protective particles in foamy macrophages and sebocytes (sebaceous glands) in the oral mucosa, and how immunosenescence and/or SARS-CoV-2 can abort trained (innate) immunity leading to increased risks of COVID-19 severity.

Read More
Carina Harkin

Carina Harkin

MPH. BHSc.Nat. BHSc.Hom. BHSc.Acu. Cert IV TAE.

Carina Harkin holds three level 8 Bachelor of Health Science degrees in Complementary and Alternative Medicine (CAM) and a Masters in Public Health. Carina was awarded by her college for being the first triple degree CAM graduate in the world. BC (before COVID), Carina chaired, moderated and presented at international CAM conferences on topics including, ‘Annual Influenza Vaccine Review of Current Attitudes, Effectiveness and Natural Evidence-Based Alternatives in the Likelihood of a Pandemic’, ‘Plastic Bioaccumulation, Health Implications and Enhancing Biotransformation using Herbal Medicine’ and ‘Heavy Metal Biotransformation using Plant Lignands Metallothioneins and Phytochelatins’.

Read More
Jessica Rose

Jessica Rose

PhD, MSc., BSc.

Dr. Jessica Rose is a Canadian researcher with a Bachelor's Degree in Applied Mathematics and a Master's degree in Immunology from Memorial University of Newfoundland. She also holds a PhD in Computational Biology from Bar Ilan University and 2 Post Doctoral degrees: one in Molecular Biology from the Hebrew University of Jerusalem and one in Biochemistry from the Technion Institute of Technology. She was also accepted for a 2-month program as a senior researcher at the Weizmann Institute prior to completion of her latest post doctoral degree at the Technion. Her more recent research efforts are aimed at descriptive analysis of the Vaccine Adverse Event Reporting System (VAERS) data in efforts to make this data accessible to the public.

Read More
Support our work
DONATE
Follow us on
Subscribe to our Newsletter
Voices for Science and solidarity, © 2021